Literature DB >> 11459288

Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double-blinded, randomized study.

I L Titlestad1, L S Ebbesen, A P Ainsworth, S T Lillevang, N Qvist, J Georgsen.   

Abstract

Allogeneic blood transfusions are claimed to be an independent risk factor for postoperative infections in open colorectal surgery due to immunomodulation. Leukocyte-depletion of erythrocyte suspensions has been shown in some open randomized studies to reduce the rate of postoperative infection to levels observed in nontransfused patients. Using a double-blinded, randomized design, we studied the postoperative infection rate in patients undergoing open colorectal surgery transfused with either leukocyte-depleted erythrocyte suspensions (LD-SAGM) or non-leukocyte-depleted erythrocyte suspensions (SAGM). Unselected patients (n 279) were allocated to receive LD-SAGM (n 139) or SAGM (n 140) if transfusion was indicated. Forty-five percent were transfused, yielding 48 patients in the LD-SAGM group and 64 in the SAGM group. Thirteen patients were excluded because they received one type of transfusion in spite of randomization to the other type. No significant differences in the rates of postoperative infections (P=0.5250) or postoperative complications (P=0.1779) were seen between the two transfused groups. Infection rates were 45% and 38% in the transfused groups and 21% and 23% in the nontransfused groups. No significant difference between the transfused groups was seen on any single infectious event, mortality rate, or duration of hospitalization. Leukocyte-depletion of erythrocyte suspensions transfused to patients undergoing open colorectal surgery does not reduce postoperative infection rates.

Entities:  

Mesh:

Year:  2001        PMID: 11459288     DOI: 10.1007/s003840100298

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  12 in total

1.  Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial.

Authors:  Birgitte Brandstrup; Hanne Tønnesen; Randi Beier-Holgersen; Else Hjortsø; Helle Ørding; Karen Lindorff-Larsen; Morten S Rasmussen; Charlotte Lanng; Lene Wallin; Lene H Iversen; Christina S Gramkow; Mette Okholm; Tine Blemmer; Poul-Erik Svendsen; Henrik H Rottensten; Birgit Thage; Jens Riis; Inge S Jeppesen; Dorthe Teilum; Anne Mette Christensen; Ben Graungaard; Frank Pott
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

2.  The abandoned controversy surrounding universal white blood cell reduction.

Authors:  Eleftherios C Vamvakas
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

Review 3.  Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality.

Authors:  Eleftherios C Vamvakas; Morris A Blajchman
Journal:  Transfus Med Rev       Date:  2010-04

4.  Perioperative blood transfusions increase infectious complications after ileoanal pouch procedures (IPAA).

Authors:  Khaled M Madbouly; Anthony J Senagore; Feza H Remzi; Conor P Delaney; Jonathan Waters; Victor W Fazio
Journal:  Int J Colorectal Dis       Date:  2006-04-01       Impact factor: 2.571

5.  Leukodepleted blood components do not remove the potential for long-term transfusion-associated microchimerism in Australian major trauma patients.

Authors:  Rena Hirani; Zsolt J Balogh; Natalie J Lott; Jeremy M Hsu; David O Irving
Journal:  Chimerism       Date:  2015-08-07

6.  Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery.

Authors:  Joost A van Hilten; Leo M G van de Watering; J Hajo van Bockel; Cornelis J H van de Velde; Job Kievit; Ronald Brand; Wilbert B van den Hout; Robert H Geelkerken; Rudi M H Roumen; Ronald M J Wesselink; Ankie W M M Koopman-van Gemert; Jan Koning; Anneke Brand
Journal:  BMJ       Date:  2004-05-13

Review 7.  Transfusion immunomodulation--the case for leukoreduced and (perhaps) washed transfusions.

Authors:  Katie L Lannan; Julie Sahler; Sherry L Spinelli; Richard P Phipps; Neil Blumberg
Journal:  Blood Cells Mol Dis       Date:  2012-09-13       Impact factor: 3.039

Review 8.  Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion.

Authors:  Daniel Simancas-Racines; Dimelza Osorio; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2015-12-03

9.  Impact of Transfusion Threshold on Infectious Complications After Ileal Pouch-Anal Anastomosis.

Authors:  Emre Gorgun; Volkan Ozben; Luca Stocchi; Gokhan Ozuner; Xiaobo Liu; Feza Remzi
Journal:  J Gastrointest Surg       Date:  2015-12-16       Impact factor: 3.452

Review 10.  Infectious and immunologic consequences of blood transfusion.

Authors:  E Patchen Dellinger; Daniel A Anaya
Journal:  Crit Care       Date:  2004-06-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.